Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William Whitehead Jr. who wrote (637)	5/6/1999 11:39:00 AM
From: StockMiser	of 2344

I think it all really depends on media exposure. We all know that Dr. McPherson was interviewed by the NY Times - so the hope is that they run an article, most likely in conjunction with the conference. As for the bridging study...they did release material information last year for the "interim". So the hope is that the final release expands on that. The 2 stem cell replacement studies with Theratope could also be significant given all that recent negative info on the ineffectiveness of stem cell therapy with chemo. If you are long, the conf is just a blip on the way to much bigger things. We will rock soon enough :) SM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next